NewsWhore
04-24-2008, 11:40 AM
<img alt="" height="1" width="1">
AstraZeneca Profit Falls as Nexium Sales Decline (Update3) (http://news.google.com/news/url?sa=T&ct=us/8-0&fd=R&url=http://www.bloomberg.com/apps/news%3Fpid%3D20601102%26sid%3Da5HP6v4jMxVc%26refer%3Duk&cid=1153544888&ei=TaoQSIWAG4WM-wHXrMH-Dg&usg=AFrqEze3sWrT6srntQ04aYYovC2BavvtUA)
Bloomberg - 1 hour ago
The UK company said core earnings per share will be $4.45 to $4.75 this year, more than previously forecast, because of currency benefits. ...
More... (http://news.google.com/news/url?sa=T&ct=us/8-0&fd=R&url=http://www.bloomberg.com/apps/news%3Fpid%3D20601102%26sid%3Da5HP6v4jMxVc%26refer%3Duk&cid=1153544888&ei=TaoQSIWAG4WM-wHXrMH-Dg&usg=AFrqEze3sWrT6srntQ04aYYovC2BavvtUA)
AstraZeneca Profit Falls as Nexium Sales Decline (Update3) (http://news.google.com/news/url?sa=T&ct=us/8-0&fd=R&url=http://www.bloomberg.com/apps/news%3Fpid%3D20601102%26sid%3Da5HP6v4jMxVc%26refer%3Duk&cid=1153544888&ei=TaoQSIWAG4WM-wHXrMH-Dg&usg=AFrqEze3sWrT6srntQ04aYYovC2BavvtUA)
Bloomberg - 1 hour ago
The UK company said core earnings per share will be $4.45 to $4.75 this year, more than previously forecast, because of currency benefits. ...
More... (http://news.google.com/news/url?sa=T&ct=us/8-0&fd=R&url=http://www.bloomberg.com/apps/news%3Fpid%3D20601102%26sid%3Da5HP6v4jMxVc%26refer%3Duk&cid=1153544888&ei=TaoQSIWAG4WM-wHXrMH-Dg&usg=AFrqEze3sWrT6srntQ04aYYovC2BavvtUA)